Onkologisches Versorgungszentrum Friedrichshain Hämatologie, Onkologie und Palliativmedizin

The medical center is at the forefront of integrating artificial intelligence with hematology to enhance patient outcomes. The ongoing research focuses on understanding and predicting hydroxyurea resistance in patients with polycythemia vera, a rare blood disorder characterized by an overproduction of red blood cells.

• Hydroxyurea Resistance Prediction
• Machine Learning in Hematology
• Personalized Treatment Approaches

By leveraging advanced machine learning techniques, the center aims to identify predictive risk factors for drug resistance, thereby tailoring treatment plans to individual patient needs and improving therapeutic efficacy.